Eli Lilly and Company on Sept. 16 announced it would invest $5 billion to build a manufacturing plant in Goochland County, Virginia. The plant, located just west of the state capital of Richmond, will be the company’s first fully integrated drug product facility and is another part of Eli Lilly’s $50 billion in domestic capital commitments since 2020, the company said in a news release.
“Our investment in Virginia underscores our commitment to U.S. innovation and manufacturing—creating high-quality jobs, strengthening communities and advancing the health and well-being of Americans nationwide,” said David A. Ricks, Lilly chair and chief executive officer.
